Table 3.
The 28-day or 90-day LT-free mortality rates in the ACLF patients with serum HBV DNA ad-level lower or higher than 2000 IU/ml or 2 × 106 IU/ml
| HBV DNA (IU/ml) | 28-day prognosis | 90-day prognosis | ||
|---|---|---|---|---|
| n | mortality, n(%) | n | mortality, n(%) | |
| <2000 | 13 | 1 (7.7) | 7 | 3 (42.9) |
| ≥2000 | 26 | 5 (19.2) | 15 | 6 (40.0) |
| <2 × 106 | 31 | 4 (12.9) | 17 | 7 (41.2) |
| ≥2 × 106 | 8 | 2 (25.0) | 5 | 2 (40.0) |
| Total | 39 | 6 (15.4) | 22 | 9 (40.9) |
1. LT: liver transplantation
2. HBV DNA <2000 IU/ml or ≥ 2000 IU/ml: 28-day LT-free mortality rates: Fisher’s exact test, P = 0.643; 90-day LT-free mortality rates: Fisher’s exact test, P = 1.000
3. HBV DNA <2 × 106 IU/ml or ≥ 2 × 106 IU/ml: 28-day LT-free mortality rates: Fisher’s exact test, P = 0.583; 90-day LT-free mortality rates: Fisher’s exact test, P = 1.000